The Imaging, Psychopathology, Cognition and Therapeutics (IMPACT) program is engaged in a broad range of studies investigating brain structure, function, chemistry, and physiology related to cognition and mood in healthy individuals and in those with psychiatric and medical disorders. The IMPACT program seeks to develop and evaluate new treatments for people with disorders of cognition and mood . The program also provides learning opportunities for clinical neuroscience research.
Who we are
The IMPACT Program seeks to develop and evaluate new treatments for people with disorders of cognition and mood. Our program provides a range of research training opportunities for psychiatric residents, post-doctoral fellows, medical students and graduate students. Our research and research training programs are supported through grants and endowments from the Federal Government, the Commonwealth of Massachusetts, Harvard Medical School, Beth Israel Deaconess Medical Center, and research foundations, as well as through the generous contributions of individual donors.
At the cutting edge of research